Rory Cristiane Fortes de Brito

Author

Universidade Federal de Ouro Preto ORCID

Also Known As

R. C. BRITO, R. N. S. BRITO, Rory C. F. De Brito, Rory Brito, Rory C. F. Brito, Rory C. F. De Brito, Rory C. F. de Brito, Rory C.F. Brito, Rory C.F. De Brito, Rory Cristiane De Brito

Publications

847

Citations

H-Index

Concepts

All Affiliations

Universidade Federal de Ouro Preto Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais Universidade Federal de Minas Gerais Fundação Oswaldo Cruz Universidade Federal de Juiz de Fora

About

Rory Cristiane Fortes de Brito is an author at Universidade Federal de Ouro Preto specializing in medicine, immunology, and parasitology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	133
2	Immunology	7	7	121
3	Pathology	3	3	44
4	Natural Sciences	1	1	18
5	Allergy	1	1	14

Rory Cristiane Fortes de Brito

Publications

414

Citations

H-Index

Page 1

	Year	Citations
Molecular diagnosis of canine visceral leishmaniasis: A comparative study of three methods using skin and spleen from dogs with natural Leishmania infantum infection Levi Eduardo Soares Reis, Wendel Coura‐Vital, Bruno Mendes Roatt, Veterinary Parasitology	2013	75
A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden Bruno Mendes Roatt, Rodrigo Dian de Oliveira Aguiar‐Soares, Levi Eduardo Soares Reis, Frontiers in Immunology	2017	45
Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T Cells That Trigger Protection against Experimental Visceral Leishmaniasis Rory Cristiane Fortes de Brito, Jerônimo Conceição Ruiz, Jamille Mirelle de Oliveira Cardoso, Vaccines	2020	37
Immunoinformatics Features Linked to Leishmania Vaccine Development: Data Integration of Experimental and In Silico Studies Rory Cristiane Fortes de Brito, Frederico Gonçalves Guimarães, João Paulo Linhares Velloso, International Journal of Molecular Sciences	2017	26
Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB/c Mice Rory Cristiane Fortes de Brito, Jamille Mirelle de Oliveira Cardoso, Levi Eduardo Soares Reis, Vaccines	2019	23
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis Thiago A.R. Reis, João A. Oliveira‐da‐Silva, Grasiele S.V. Tavares, Experimental Parasitology Antiparasitic AgentLeishmania InfantumMedicineParasitic ProtozoaImmunology	2020	23
Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice Levi Eduardo Soares Reis, Rory Cristiane Fortes de Brito, Jamille Mirelle de Oliveira Cardoso, Antimicrobial Agents and Chemotherapy	2017	22
A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB/c mice Thais Lopes Valentim Di Paschoale Ostolin, Miriã Rodrigues Gusmão, Fernando Augusto Siqueira Mathias, Vaccine VaccinationMucosal VaccinationImmunologyImmunodominanceTherapeutic Vaccine	2021	22
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis Camila S. Freitas, João A. Oliveira‐da‐Silva, Daniela P. Lage, Parasitology Research Medicinal ChemistryBioorganic ChemistrySelective Antileishmanial ActionAntiparasitic AgentLeishmania Infantum	2020	18
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis Rafaella R. Costa, João A. Oliveira‐da‐Silva, Thiago A.R. Reis, Medical Microbiology and Immunology Vivo Antileishmanial ActivityAntiparasitic AgentMedicineParasitic ProtozoaImmunology	2021	15

Page 1